CURX
Curanex Pharmaceuticals Inc Common Stock
NASDAQ · Healthcare · Biotechnology · US
$5.16
+8.86%Institutional positioning
13F filings over the trailing two quarters
New 2Increased 3Reduced 4Sold out 7
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 111,130 | May 15, 2026 |
| CITADEL ADVISORS LLC | Increased | 95,258 | Sep 2, 2026 |
| TWO SIGMA SECURITIES, LLC | New Position | 56,651 | May 15, 2026 |
| XTX TOPCO LTD | Increased | 51,289 | May 15, 2026 |
| CITADEL ADVISORS LLC | Reduced | 50,559 | May 15, 2026 |
| TWO SIGMA INVESTMENTS, LP | Reduced | 20,254 | May 15, 2026 |
| CITIGROUP INC | New Position | 19,332 | May 11, 2026 |
| JUMP FINANCIAL, LLC | Reduced | 10,551 | May 14, 2026 |
| UBS GROUP AG | Reduced | 7,995 | May 5, 2026 |
| XTX Topco Ltd | Sold Out | 0 | May 15, 2026 |
| Jump Financial, LLC | Sold Out | 0 | May 14, 2026 |
| TWO SIGMA SECURITIES, LLC | Sold Out | 0 | May 15, 2026 |
| CITIGROUP INC | Sold Out | 0 | May 11, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Sold Out | 0 | May 15, 2026 |
| UBS Group AG | Sold Out | 0 | May 5, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings